1 |
33078873 |
10.1002/gcc.22901 |
2022 |
Rare and novel RUNX1 fusions in myeloid neoplasms: A single-institute experience. |
MECOM |
2 |
31649131 |
10.3324/haematol.2019.225953 |
2021 |
EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase. |
MECOM |
3 |
31711889 |
10.1016/j.clml.2019.09.615 |
2021 |
Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM. |
MECOM |
4 |
32189545 |
10.1080/10428194.2020.1737689 |
2021 |
Prognosis of <i>MECOM</i> (<i>EVI1</i>)-rearranged MDS and AML patients rather depends on accompanying molecular mutations than on blast count. |
MECOM |
5 |
30784060 |
10.1111/bjh.15799 |
2020 |
Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study. |
MECOM |
6 |
31554743 |
|
2020 |
MECOM: A Very Interesting Gene Involved also in Lymphoid Malignancies. |
MECOM |
7 |
31648321 |
10.1182/bloodadvances.2019000404 |
2020 |
Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia. |
MECOM |
8 |
29214881 |
10.1080/10428194.2017.1406089 |
2019 |
Ecotopic viral integration site 1 (EVI1) transcriptionally targets talin1 (TLN1) and upregulates its expression in chronic myeloid leukemia. |
MECOM |
9 |
29666005 |
10.1016/j.cancergen.2018.01.003 |
2019 |
Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci. |
MECOM |
10 |
29846125 |
10.1080/10428194.2018.1459615 |
2019 |
EVI1 expression predicts outcome in higher-risk myelodysplastic syndrome patients. |
MECOM |
11 |
27967290 |
10.1080/10428194.2016.1266622 |
2018 |
Ecotropic viral integration site I regulates alpha1, 6-fucosyl transferase expression and blocks erythropoiesis in chronic myeloid leukemia. |
MECOM |
12 |
24828867 |
10.3109/10428194.2014.924118 |
2016 |
Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia. |
MECOM |
13 |
25907616 |
10.3109/10428194.2015.1043547 |
2016 |
A murine model of acute myeloid leukemia with Evi1 overexpression and autocrine stimulation by an intracellular form of GM-CSF in DA-3 cells. |
MECOM |
14 |
25936528 |
10.1038/leu.2015.114 |
2016 |
The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL. |
MECOM |
15 |
23772643 |
10.3109/10428194.2013.815350 |
2015 |
EVI1 targets platelet endothelial cell adhesion molecule and up-regulates its expression in chronic myeloid leukemia. |
MECOM |
16 |
24327541 |
10.1002/gcc.22124 |
2014 |
The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1. |
MECOM |
17 |
24856998 |
|
2014 |
[Clinical characteristics of childhood leukemia with EVI1 gene and BCR/ABL gene co-expression]. |
MECOM |
18 |
22828445 |
10.1038/leu.2012.211 |
2013 |
EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia. |
MECOM |
19 |
23054648 |
10.1007/s12185-012-1185-8 |
2013 |
Acquired EVI1 rearrangement involved in the transformation from 5q- syndrome to pre-B lymphocytic leukemia in a Chinese patient. |
MECOM |
20 |
22050763 |
10.1111/j.1365-2141.2011.08918.x |
2012 |
PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies. |
MECOM |
21 |
18809762 |
10.1182/blood-2008-04-148791 |
2009 |
BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemias. |
MECOM |
22 |
19010836 |
10.1158/1078-0432.CCR-07-5051 |
2009 |
Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia. |
MECOM |
23 |
17169788 |
10.1080/10428190601040258 |
2007 |
Dysregulated EVI1 expression in myeloid malignancies. |
MECOM |
24 |
17169810 |
10.1080/10428190600942561 |
2007 |
Reverse transcriptase-polymerase chain reaction based quantification of the combined MDS-EVI1/EVI1 gene in acute myeloid leukemia. |
MECOM |
25 |
17074597 |
10.1016/j.cancergencyto.2006.07.004 |
2006 |
Screening for EVI1: ectopic expression absent in T-cell acute lymphoblastic leukemia patients and cell lines. |
MECOM |
26 |
9861236 |
10.1093/jjco/28.11.688 |
1998 |
Acute myelogenous leukemia with monosomy 7, inv(3) (q21q26), involving activated EVI 1 gene occurring after a complete remission of lymphoblastic lymphoma: a case report. |
MECOM |
27 |
9009083 |
10.1038/sj.leu.2400547 |
1997 |
Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia. |
MECOM |
28 |
9031072 |
10.3109/10428199609054850 |
1997 |
Pattern of expression and their clinical implications of the GATA family, stem cell leukemia gene, and EVI1 in leukemia and myelodysplastic syndromes. |
MECOM |
29 |
8656673 |
|
1996 |
Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia. |
MECOM |
30 |
8932329 |
10.1038/bjc.1996.583 |
1996 |
Expression of the zinc finger gene EVI-1 in ovarian and other cancers. |
MECOM |